References
- Gaulard P, Swerdlow SH, Harris NL, et al. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al., editors. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Vol Revised 4th ed. Lyon: IARC Press; 2017; p. 462–464.
- Shimada K, Matsui T, Kawakami M, et al. Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol. 2007;36:64–67.
- Kameda H, Okuyama A, Tamaru J, et al. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol. 2007;26:1585–1589.
- Schalk E, Krogel C, Scheinpflug K, et al. Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera. Onkologie. 2009;32:440–441.
- Inaba M, Ushijim S, Hirata N, et al. Methotrexate-related lymphomatoid granulomatosis in a patient with rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi (in Japanese). 2011;49:597–601.
- Kobayashi S, Kikuchi Y, Sato K, et al. Reversible iatrogenic, MTX-associated EBV-driven lymphoproliferation with histopathological features of a lymphomatoid granulomatosis in a patient with rheumatoid arthritis. Ann Hematol. 2013;92:1561–1564.
- Ogata T, Shibata S, Matsuoka E, et al. A case of Methotrexate-associated lymphomatoid granulomatosis. Japan J Lung Cancer. 2013;53:234–239.
- Yamakawa T, Kurosawa M, Yonezumi M, et al. Methotrexate-related lymphomatoid granulomatosis successfully treated with discontinuation of methotrexate and radiotherapy to brain. Rinsho Ketsueki (in Japanese). 2014;55:321–326.
- Blanchart K, Paciencia M, Seguin A, et al. Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis. Minerva Anestesiol. 2014;80:119–120.
- Ochi N, Yamane H, Yamagishi T, et al. Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis. J Clin Oncol. 2013;31:e348–e350.
- Oiwa H, Mihara K, Kan T, et al. Grade 3 lymphomatoid granulomatosis in a patient receiving methotrexate therapy for rheumatoid arthritis. Intern Med. 2014;53:1873–1875.
- Barakat A, Grover K, Peshin R. Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis. Springerplus. 2014;3:751.
- Ito S, Shiraishi M, Iwai Y, et al. A case of methotrexate-associated lymphomatoid granulomatosis diagnosed on autopsy. Jichi Med Univ J. 2015;38:65–60.
- Ishihara S, Izumi H, Nagase D, et al. Multiple Lung Tumors Assumed to Be Rapidly Advancing Methotrexate-associated Lymphoproliferative Disease. J New Rem and Clin. 2015;64:183–189.
- Tanaka H, Furukawa S, Takeda Y, et al. Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy. Intern Med. 2015;54:503–507.
- Nagaoka S, Nakamura M, Senuma A, et al. Diversity of nodular lesions in patients with rheumatoid arthritis and methotrexate treatment. Jpn J Clin Immunol. 2005;28:389–374.
- Watanabe H, Masuda R, Matsuzaki T, et al. A surgical case of methotrexate-associated lymphomatoid granuloma. Gen Thorac Cardiovasc Surg. 2018;66:435–438.
- Aiko N, Sekine A, Umeda S, et al. The spontaneous regression of grade 3 methotrexate-related lymphomatoid granulomatosis: a case report and literature review. Intern Med 2018. DOI:10.2169/internalmedicine.0542-17
- Pittaluga S, Wilson WH, Jaffe ES, et al. Lymphomatoid granulomatosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumors of Haematopoietic and Lymphoid Tisuues. Vol Revised 4th ed. 2017. Lyon: IARC Press; p. 312–14.
- Miyazaki T, Fujimaki K, Shirasugi Y, et al. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol. 2007;82:1106–1109.
- Sasaki S, Kondo Y, Suzuki Y, et al. The 62nd annual general assembly and scientific meeting of the Japan college of rheumatology; 26 April 2018; Tokyo, Japan.